Autres langues Pacific Biosciences of California, Inc.

Actions

PACB

US69404D1081

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 13/10/2026			Varia. 5j.	Varia. 1 janv.
2,050 ^USD	-2,38%		-24,07%	+9,63%

08/10	Un initié de Pacific Biosciences of California a vendu des actions pour 2 056 921 dollars, selon un récent dépôt auprès de la SEC	MT
06/10	Pacific Biosciences of California et TychoBio collaborent pour produire des données d’ARN pleine longueur destinées à l’entraînement de modèles d’IA	MT

Autres langues

08/10	Pacific Biosciences of California Insider Sold Shares Worth $2,056,921, According to a Recent SEC Filing
06/10	Pacific Biosciences of California, TychoBio Collaborate to Generate Full-Length RNA Data for AI Model Training
06/10	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
06/10	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
04/09	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference
03/09	PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
05/08	Pacific Biosciences: Q2 Earnings Snapshot
05/08	Pacific Biosciences Announces Restructuring Plan, Cutting 8% of Workforce to Drive Up to $40 Million in Annual Savings by 2027
05/08	Pacific Biosciences of California, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
05/08	PacBio Announces Second Quarter 2026 Financial Results
05/08	PacBio Appoints Mark Van Oene as President and Chief Executive Officer
05/08	Pacific Biosciences of California, Inc. Announces CEO Changes, Effective August 5, 2026
05/08	Pacific Biosciences of California, Inc. Announces President Changes, Effective August 5, 2026
05/08	Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Full Year of 2026
05/08	PacBio Announces Availability Of SPRQ-Nx Chemistry And Software Update For Vega System
05/08	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
28/07	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
15/07	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07	Pacific Biosciences of California, Inc. Announces Resignation of Christopher M. Smith from Director, Effective July 8, 2026
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell Small Cap Comp Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2500 Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 2000 Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000E Growth Benchmark
29/06	Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000 Growth Benchmark
26/05	Pacbio Ships Sprq-Nx Chemistry and Multi-Use Smrt Cells for Revio Hifi Sequencing Platform Worldwide